placeSouth Africa
Contact us
Minimally Invasive Therapies / Products / Hemostasis / Veriset™

You are entering HCP content only

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

Overview

The confidence to know bleeding will stop

We developed the Veriset™ hemostatic patch based on six years of scientific research and development. It’s designed to help you achieve hemostasis quickly and consistently.1,2,3,†

Unique Mode of Action

The Veriset™ patch is placed over the injury, gentle pressure is applied for 30 seconds.1,2,4

Bleeding has stopped at approximately 1 min.1,2,3,†

HOW IT WORKS

Fast & Reliable

The Veriset™ patch works in two ways:

Denaturation of red blood cells, resulting in a lower pH and platelets, which are essential for hemostasis, becoming 'trapped' in the oxidised regenerated  cellulose, both these events result in the expedition of the bodies own natural coagulation cascade.5

And secondly once the patch is activated, via the combination of Trilysine and Polyethylene Glycol, a PEG Hydrogel is formed. This Hydrogel has two effects: firstly to adhere the patch to the tissue and secondly to form a seal across the damaged tissue. 1,6

Both parts together help to ensure high efficacy hemostasis can be achieved.

Easy to Use

Ready to use in both open and laparoscopic procedures with no preparation time4,7

Store Veriset™ Hemostatic Patch at room temperature <25oC 8,9

Designed to easily pass through a trocar7

Not contraindicated in a contaminated or infected environment9

Fast And Reliable

  • 78% of liver surgery patients achieve hemostasis in ≤1 minute1,10,†
  • Hold for only 30 seconds1,2,4
  • Single application sufficient to stop most bleeds1,2

Increased Patient Safety

  • Maintains efficacy post-surgery - no re-operative device related bleeding reported after 5 days1,2
  • Patch is fully absorbed in approximately 28 days10
  • Offers bactericidal properties9

Effective

  • Effective in cases of inhibited coagualation, independent of clotting ability11,12
  • Achieve hemostasis quickly and consistently - 66% faster than TachoSil™* fibrin patch1,10

What Our Customers Say

Effective in cases of inhibited coagulation and independent of clotting ability11,12

"The Veriset™ patch does not require a patient to have a perfect coagulopathy." 

"It is easy to handle without any difficulties, even in laparoscopic surgery."

Clinical Evidence

Achieved hemostasis significantly faster than the control device1,10 

The Veriset™ hemostatic patch is effective in promoting hemostatis and does not elicit any safety concerns.2

Regardless of bleeding severity or surface area, the Veriset™ hemostatic path achieved hemostasis significantly faster than the control device in patients undergoing hepatic resection. It was safe and easy to handle in open hepatic surgery.1,7,10

Order Information

Click below to learn about the available order options.

Resources

  • 1. Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ hemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery [published online Dec. 27, 2012]. HPB (Oxford). 2013;15(7):548-58. doi: 10.1111/hpb.12009.
  • 2. Schuhmacher C, Pratschke J, Weiss S, et al. Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding. Med Devices. 2015;8:167–174.
  • 3. Glineur D, Hendrikx M, Krievins D, et al. A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding. Med Devices: Evidence and Research. 2018;11:65-75
  • 4. Based on internal test report # TR1431, Hemostasis Patch: Evaluation of Product Performance Against Product Specification in an Acute Pre-Clinical Model. June 2010
  • 5. Bajerova Martina, Krejcova Katerina, Rabiskova Miloslava, et al. Oxycellulose: Significant Characteristics in Relation to Its Pharmaceutical and Medical Application. Advances in Polymer Technology. Vol. 28, No. 3, pp. 199–208. Science Direct. Oxidized Cellulose. https://www.sciencedirect.com/topics/neuroscience/oxidized-cellulose. Accessed Feb. 25, 2020.
  • 6. Based on internal test report TR1444, Long-term Evaluation of a Polyethylene Glycol(PEG)/Oxidized Cellulose Hemostatic Patch after Liver Resection in a Porcine Model. June 2011.
  • 7. Based on internal test report #TR1478, Evaluation of Veriset™ after Laparoscopic Liver Resection in Porcine Model. June 2013
  • 8. Based on internal testing report #TR1477, Veriset Stability at Maximum Irradiation Dose - 104 week Final Report. March 2015
  • 9. Veriset Hemostatic Patch [instruction for use], North Haven, CT - USA : Medtronic 2018
  • 10. Based on internal report #COVEULV0032, A Prospective, Multi-Center, Randomized, Single-Blind Study to Compare the Hemostatic Patch to Fibrin Sealant TachoSil™* in Subjects undergoing Hepatic Surgery, appendix B. January 2012.
  • 11. Based on internal test report #COVEUCV0140-CSR - A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil™* as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery. March 2014.
  • 12. Based on internal testing report #TR1428, Evaluation of a Polyethylene Glycol (PEG)/Oxidized Cellulose Hemostatic Patch on the Anastomotic site in a Porcine CABG Model. March 2011
CORPORATE RESOURCES
Minimally Invasive Therapies
Medtronic Africa

Waterfall Distribution Campus

Corner K101 & Bridal Veil Road

Waterfall, Midrand, Gauteng

1685

South Africa

©2025 Medtronic